Positivity of macrophages only for CD163 has been found to be associated with tumor stage and lymph node status (16), whereas macrophage positivity for only CD68 has been associated with the molecular subtype of breast cancer, independent of other clinicopathological parameters. This evidence concerns the gene CD163 and breast carcinoma.